Article

Alcon symposium draws 300 to hear ReSTOR, AquaLase experiences

Emerging lens extraction and implantation technologies have worldwide appeal among ophthalmologists, and at the European Society of Cataract and Refractive Surgeons meeting, it was evident at an evening symposium conducted by Alcon Laboratories.

Paris—Emerging lens extraction and implantation technologies have worldwide appeal among ophthalmologists, and at the European Society of Cataract and Refractive Surgeons meeting, it was evident at an evening symposium conducted by Alcon Laboratories.

Amidst the elegant backdrop of the Pavillon Gabrielle, about 300 physicians and their guests heard world-known ophthalmologists share their experiences about the company's pseudoaccommodative IOL, AcrySof ReSTOR, and the AquaLase liquefaction device on the Infiniti phacoemulsification system.

Moderated by Donald Serafano, MD, of the United States, the panel looked at the design and clinical experiences of the ReSTOR lens, the clinical experiences with AquaLase, and the emerging technologies ahead.

David Allen, MD, of the United Kingdom, started the discussion detailing the design of the ReSTOR lens and its role in improving vision for patients with presbyopia.

Rudy Nuijts, MD, of the Netherlands, continued the ReSTOR discussion by outlining his clinical experiences with the lens. He reportedly has placed the lens in 63 eyes of 32 patients, 31 bilaterally and 1 unilaterally. His refractive outcomes show 90% with a spherical equivalent of ±0.5 D and 100% with a spherical equivalent of 0.75 D. Dr. Nuijts also showed comparative data of how ReSTOR fares with the ARRAY lens.

The discussion shifted to AquaLase when Philippe Crozafon, MD, of France, presented his first-year experiences with the liquefaction device. Dr. Crozafon described the technology behind AquaLase and discussed the features of the waterjet in the AquaLase handpiece. He outlined the advantages that AquaLase brings to lens extraction and compared it with the ultrasound technology.

Dr. Crozafon reported that he has performed 449 procedures using AquaLase on grade 1+ to 3+ cataracts. He has had few complications among those cases.

Robert Cionni, MD, of the United States, wrapped up the program reviewing emerging technologies in cataract removal and lens implantation and what the future may hold for physicians with these technologies.

Dr. Cionni also offered some words of advice. He pointed out that technology has improved over the years, creating better outcomes for patients. The downside is that patients will have higher expectations when it comes to their vision. However, the emerging technologies will help physicians meet those expectations.

Finally, the physicians and their guests closed the evening experiencing the elegance of Pavillon Gabrielle with food, drink, and entertainment. A good time was had by all!

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.